Physician
Hematology
Dr. Barry R. Meisenberg, MD
|
|
Give Review
Doctor Barry R. Meisenberg, MD works in the field of Hematology. He researched medicine at Albany Medical College. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Whos Who in Medicine and Healthcare". Barry Meisenberg is a published doctor and has 58 publications published. The lastest was: 'Academic oncology and the forces of the marketplace: crisis cloaks opportunity.' Barry Meisenberg accepts Medicare payments and is registered with Medicare.gov.
Publications
- Improving hospital performance in the treatment of febrile neutropenia.
- The Political Use of the Cancer Metaphor: Negative Consequences for the Public and the Cancer Community.
- A supportive care clinic for Cancer patients embedded within an oncology practice.
- Balancing Incentives and Professionalism in Health Care Payment Reform.
- Colony-stimulating factors and neutrophil migration.
- A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal Cancer.
- A radiologic Syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis.
- Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramos...
- Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support.
- Etoposide for metastatic breast Cancer.
- Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients With bone marrow failure.
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast Cancer.
- Role of cytokines in autologous bone marrow transplantation.
- Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin Lymphoma.
- Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
- Phase I trial of intravenous and intraperitoneal administration of granulocyte-macrophage colony-stimulating factor.
- P. carinii pneumonia (PCP) following tandem cycles of high-dose chemotherapy and autologous PBPC support.
- Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
- High-dose chemotherapy and autologous stem cell support for patients With malignant melanoma.
- Autotransplantation for advanced Lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.
- Fatal disseminated adenoviral infection Associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation.
- Radiation retinopathy: the role of pentoxifylline.
- Pulmonary toxicity Syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy.
- Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenit...
- Treatment of Acute myelogenous leukemia.
- A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
- Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
- Influence of preapheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis.
- Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin''s Lymphoma.
- Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.
- High-dose cyclophosphamide With or Without etoposide for mobilization of peripheral blood progenitor cells in patients With multiple myeloma: efficacy and toxicity.
- A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing periph...
- Autologous stem cell transplantation followed by consolidation chemotherapy for patients With multiple myeloma.
- Human brain endothelial cells (HUBEC) promote SCID repopulating cell expansion through direct contact.
- Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for inDuction and stem cell mobilization in patients with multiple myeloma.
- Phase I clinical trial assessing temozolomide and tamoxifen With concomitant radiotherapy for treatment of high-grade glioma.
- Metastasis of a histologically benign--appearing meningioma to the iliac bone.
- Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination With dexamethasone and thalidomide in relapsed multiple myeloma patients.
- Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
- Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.
- ChorioCarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a c...
- Outpatient high-dose chemotherapy with autologous stem-cell rescue for Hematologic and nonHematologic malignancies.
- Mobilized peripheral blood progenitor cells (PBPC) in support of tandem cycles of high-dose chemotherapy (HDC).
- High-dose ifosfamide, carboplatin, and etoposide With autologous stem-cell support.
- Phase I study of docetaxel and topotecan in patients With solid tumors.
- Pharmacokinetic and pharmacodynamic study of the combination of docetaxel and topotecan in patients With solid tumors.
- Academic oncology and the forces of the marketplace: crisis cloaks opportunity.
- Reduced charges and costs Associated with outpatient autologous stem cell transplantation.
- Randomized trial of high-dose chemotherapy With autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma.
- Case study: CC, a premenopausal 43-year-old woman, found a lump under her arm.
- Granulocyte colony stimulating factor (G-CSF) for mustard-induced bone marrow suppression.
- Thrombotic Thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive males.
- A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy.
- An all oral antiemetic regimen for patients undergoing high-dose chemotherapy With peripheral blood stem cell transplant.
- Complications associated with Central venous catheters used for the collection of peripheral blood progenitor cells to support high-dose chemotherapy and autologous st...
- Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin Lymphoma.
- FDG PET/CT findings in Acute adult mononucleosis mimicking malignant lymphoma.
Schools
Albany Medical College
US Naval Hospital
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
Education
-
Naval Medical Center -
Albany Medical College
Hospital
-
Anne Arundel Medical Center
Drug Facts
| NPI NUMBER | 1295779759 | |
| NPPES Provider LastName | MEISENBERG | |
| NPPES Provider FirstName | BARRY | |
| NPPES Provider ZIPCode | 214013280 | |
| NPPES Provider State | MD | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 150.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295779759 |
| Last Name Of The Provider | MEISENBERG |
| First Name Of The Provider | BARRY |
| View All |
Similar Doctors
|
|
Dr. Jason D. Taksey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen A. Kemmer, MD |
|
|
Dr. Jeanine L. Werner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Durocher, MD |
|
|
Dr. Stuart E. Selonick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arun Bhandari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Young J. Lee, MD |
|
|
Dr. Russell R. Deluca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Heather L. Tracy, LCPC |
|
|
Dr. Stanley P. Watkins Jr., MD
This Doctor is OpenDoctor Recommended.
|